The medical management of hepatocellular carcinoma (HCC) in Japan: A review with implications for HCC seen in the West

Hepato-Gastroenterology

Volumn 43, Issue 12, 1996, Pages 1575-1583

  Ichida, Takafumi ^a   Van Thiel, David H ^b   Hassanein, Tarek ^b  

^a NIIGATA UNIVERSITY   (Japan)

^b UNIVERSITY OF KENTUCKY MEDICAL CENTER   (United States)

Author keywords

Hepatic cancer; Hepatocellular cancer; Hepatoma; Primary liver cell cancer

Indexed keywords

ALCOHOL; ANTINEOPLASTIC AGENT; CISPLATIN; EPIRUBICIN; IODINATED POPPYSEED OIL; IODINE 131; IOPAMIDOL;

ADOPTIVE IMMUNOTHERAPY; ALGORITHM; ARTICLE; ARTIFICIAL EMBOLISM; BONE MARROW SUPPRESSION; EARLY DIAGNOSIS; HUMAN; JAPAN; KIDNEY DISEASE; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; METHODOLOGY; PRIORITY JOURNAL;

ANTINEOPLASTIC AGENTS; CARCINOMA, HEPATOCELLULAR; CONTRAST MEDIA; DRUG CARRIERS; EMBOLIZATION, THERAPEUTIC; ETHANOL; HUMANS; INJECTIONS, INTRALESIONAL; IODIZED OIL; JAPAN; LIVER NEOPLASMS;

EID: 0030444731     PISSN: 01726390     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (37)

1. The Liver Cancer Study Group of Japan. Primary liver cancer in Japan, features and results of surgical treatment. Annals of Surgery 1990; 211: 277-287.
2. The Liver Cancer Study Group of Japan. Survey and follow-up study of primary liver cancer in Japan. Report 10-. Acta Hepatol Jap 1993; 23: 805-813 (in Japanese with English abstract)
3. Ebara M, Ohto M, Shinagawa T, et al. Natural history of minute hepatocellular smaller than three centimeters complicating cirrhosis. Gastroenterology 1986; 90: 289-298.
4. Colombo M. Hepatocellular carcinoma. J Hepatol 1992; 15: 225-236.
5. Saito I, Miyamura T, Ohbayashi A, et al. Hepatitis C virus infection is associated with the development of hepatocellular carcinoma. Proc Natl Acad Sci USA 1990; 87: 6547-6549.
6. Yu MC, Tong MJ, Coursaget P, et al. Prevalence of hepatitis B and C viral markers in black and white patients with hepatocellular carcinoma in the United States. J Natl Cancer Inst 1990; 82: 1038-1041.
7. Okuda K, Nakashima T, Kojiro M, et al. Hepatocellular carcinoma without cirrhosis in Japanese patients. Gastroenterology 1989; 97: 140-146.
8. Endo Y. Lectin-binding analysis of serum alpha-fetoprotein: Predictive importance of the change of AFP sugar chain in the development of hepatocellular carcinoma. In: Primary Liver Cancer in Japan. Edited by T Tobe, H Kameda, M Okudaira et al, Springer-Verlag, Tokyo, Berlin, Heidelberg, et al., 1992, pp. 163-173.
9. Liebman HA, Furlie BC, Tong MJ, et al. Des-r-carboxy (abnormal) prothrombin as a serum marker of primary hepatocellular carcinoma. N Engl J Med 1984; 310: 1427-1431.
10. Majima Y, Tanikawa K. Small liver cancer-Clinical aspects. In: Atlas of Differential Diagnosis of Cancer - Liver, Edited by M. Okudaira, R Mizumoto, K Tanikawa, Bunkoudou, Tokyo, 1991, pp 35-43 (in Japanese).
11. Shinagawa T, Ohto M, Kimura K, et al. Diagnosis and clinical features of small hepatocellular carcinoma with emphasis on the utility of real-time ultrasonography. A study in 51 patients. Gastroenterology 1984; 86: 495-502.
12. Moss AA, Goldberg HI, Stark DD, et al. Hepatic tumors: Magnetic resonance and CT appearance. Radiology 1984; 150: 141-147.
13. Sakaguchi S, Tohara K, Oka Y. Ultrasonographic diagnosis of hepatocellular carcinoma. In: Primary Liver Cancer in Japan. Edited by T Tobe, H Kameda, M Okudaira et al., Springer-Verlag, Tokyo, Berline, Heidelberg, et al., 1992, pp 111-151.
14. The Study Group of Liver Tumor Biopsy (Director K Tanikawa): Reports of complications and side effects by liver tumor biopsy and percutaneous ethanol injection therapy. In: Liver Tumor Biopsy, Edited by K. Tanikawa, Kokusai Isho Shuppan Co., Tokyo, 1990, pp 209-211 (in Japanese).
15. Breedis C, Young C. The blood supply of neoplasms in the liver. Am J Pathol 1954; 30: 969-985.
16. Ichida T, Kojima T, Nakano M, et al. Clinico-pathological study of transcatheter arterial embolization therapy for hepatocellular carcinoma: first report. Acta Hepatol Jap 1981; 22: 1264-1275 (in Japanese with English abstract).
17. The Liver Cancer Study Group of Japan. The general rules for the clinical and pathological study of primary liver cancer. Jpn J Surg 1989; 19: 98-129.
18. Kasugai H, Kejima J, Tatsuta M, et al. Treatment of hepatocellular carcinoma by transcatheter arterial embolization combined with intra-arterial infusion of a mixture of cisplatin and ethiodized oil. Gastroenterology 1989; 97: 965-971.
19. Ichida T, Katoh M, Hayakawa M, et al. Therapeutic effect of a CDDP-epirubicin- lipiodol emulsion on advanced hepatocellular carcinoma. Cancer Chemother Pharmacol 1994; 33: s74-75.
20. Ikeda K, Kumada H, Saitoh S, et al. Effect of repeated transcatheter arterial embolization on the survival time in patients with hepatocellular carcinoma: Analysis by the Cox proportional hazard model. Cancer 1991; 68: 2150-2104.
21. Furui S, Otomo K, Itai M. Hepatocellular carcinoma treated by transcatheter arterial embolization: Progress evaluation by computed tomography. Radiology 1984; 159: 773-778.
22. Tanaka K, Okazaaki H, Nakamura S, et al. Hepatocellular carcinoma treated with a combination therapy of transarterial catheter embolization and percutaneous ethanol injectyion. Radiology 1991; 179: 713-717.
23. Ichida T, Hyuchi K, Arakawa K, et al. Treatment of hepatocellular carcinoma utilizing lymphokine-activated killer cells and interleukin-2 Cancer Chemother. Pharmacol. 1994; 23: 545-548.
24. Yumoto Y, Jinno K, Tokuyarna K, et al: Hepatocellular carcinoma detected by iodized oil. Radiology 1985; 154: 19-24.
25. Ichida T, Katoh M, Hayakawa M, et al. Treatment of hepatocellular carcinoma with CDDP-epirubicin-lipiodol suspension: a pilot clinico-pharmacological study. Cancer Chemother Pharmacol 1992; 31: s51-54.
26. Katoh M, Ichida T, Satoh H, et al. Intra-arterial infusion therapy for hepatocellular carcinoma with CELE. Drug Delivery System 1992; 7: 423-429 (in Japanese with English abstract).
27. Madsen MT, Park CH, Thakur ML. Dosimetry of iodine-131-ethiodol in the treatment of hepatoma. J Nucl Med 1988; 29:1038-1044.
28. Leung WT, Lau WY, Ho S, Chan M, Leung N, Lim J, Ho KC, Metreueli C, Johnson PJ, Li AKC. Selective internal radiation therapy with intra-arterial icdine-131-lipoidal in inoperable hepatocellular carcinoma. J Nucl Med 1994;35:1313-1318.
29. Raoul JL, Guyader D, Bretagne JF, Ducauferrier R, Bourguet P, Bekhechi A, Deugnier Ylvl, Gosselini M. Randomized controlled trial for HCC with portal vein thrombosis. Intra-arterial iodine-131 iodized oil vs. medical support. J Nucl Med 1994;35: 1782-1787.
30. Sheu JC, Huang GT, Chen DS, et al. Small hepatocellular carcinoma: Intratumor ethanol treatment using new needle and guidance systems. Radiology 1987; 163: 43-48.
31. Shiina S, Yasuda H, Muto H, et al. Percutaneous ethanol injection in the treatment of liver neoplasms. AJR 1987; 149: 949-952.
32. Ebara M, Ohto M, Sugiura N, et al. Percutaneous ethanol injection for the treatment of small hepatocellular carcinoma: Study of 95 patients. J Gastroenterol Hepatol 1990; 5: 616-626.
33. Tanikawa K. Multi-disciplinary treatment of hepatocellular carcinoma. In: Primary Liver Cancer in Japan. Edited by T Tobe, H Rameda, M Okudaira et al., Springer- Verlag, Tokyo, Berling, Heidelberg, et al., 1992, pp 139-151.
34. Majima Y, Fujimoto T, Tanikawa K: Treatment of small liver cancer-indication and prognosis: Percutaneous ethanol injection therapy. Rinshousyoukakinaika 1992; 7: 531-536 (in Japanese).
35. Shiina S, Tagami K, Terano A. Practice of percutaneous ethanol injection therapy. Naika 1991; 68: 1079-1083 (in Japanese).
36. Ebara M, Kita K, Ohto M, et al. Percutaneous ethanol injection. In: Common Disease: Liver Cirrhosis and Hepatocellular Carcinoma, edited by Y Muto, Nankoudou, Tokyo, 1990, pp 175-182 (in Japanese).
37. Ichida T, Watanabe M, Satoh T, et al. Indication and limitation of percutaneous ethanol injection therapy for hepatocellular carcinoma. Chronic Disease 1993; 4: 422-430 (in Japanese).